Education
About Us
Working with TipRanks
Follow Us
Amarin Corporation Plc (AMRN)
NASDAQ:AMRN
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.02Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 12, 2025
|% Change Since: -6.38%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. While Amarin demonstrated strong financial foundation, global expansion progress, and effective cost management, significant challenges persist in the U.S. market due to generic competition, resulting in a revenue decline and increased net loss. The commitment to research and development offers potential future growth opportunities.Company Guidance
In the conference call discussing Amarin Corporation's financial results for the fourth quarter and full year 2024, the company highlighted its strategic plans and achievements. Amarin reported a strong financial position with revenues exceeding $200 million in 2024 and a cash reserve of nearly $300 million, without any debt. The company has successfully secured regulatory approvals for its product, VASCEPA, in 49 markets globally and launched in over 20 markets. During the fourth quarter of 2024, Amarin's total net revenue was $74.7 million, with U.S. product revenue contributing $44.2 million, a decline from the previous year due to generic competition and decreased volume. European product revenue increased by $2.5 million from the prior year, reaching $4 million, primarily driven by growth in Spain and the UK. The company is also focusing on maintaining its NASDAQ listing by initiating a ratio change to its American Depositary Shares (ADS) program. Moving forward, Amarin aims to maintain its financial stability, expand VASCEPA's global reach, and continue its investment in research to maximize shareholder value and address cardiovascular disease, the leading cause of death worldwide.}}}Strong Financial Foundation
Amarin reported 2024 revenues of over $200 million and ended the year with a cash position of $294 million and no debt, providing a long runway for the company.
VASCEPA's Global Expansion
VASCEPA has been launched in over 20 markets globally with nine partnerships in place, and secured regulatory approvals in 49 markets around the world.
European Market Progress
Secured pricing and reimbursement in 10 European markets and achieved a $2.5 million increase in European product revenue year-over-year, driven by contributions from Spain and the UK.
Advancements in Research and Development
Supported more than 500 publications on icosapent ethyl, with 45 new publications in 2024, and secured more than 50 clinical guidelines and scientific statements globally.
Cost Management and Cash Preservation
Reduced year-over-year operating expenses by 26% and maintained a stable cash position with only a 5% decline since the end of 2022.
---
AMRN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AMRN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 12, 2025 | $0.47 | $0.40 | -14.89% |
| Oct 30, 2024 | $0.60 | $0.58 | -3.33% |
| Jul 31, 2024 | $0.78 | $0.68 | -12.82% |
| May 01, 2024 | $0.92 | $0.84 | -8.70% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Amarin Corporation Plc (AMRN) report earnings?
Amarin Corporation Plc (AMRN) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Amarin Corporation Plc (AMRN) earnings time?
Amarin Corporation Plc (AMRN) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AMRN EPS forecast?
AMRN EPS forecast for the fiscal quarter 2025 (Q1) is -0.04.
---